Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
1 other identifier
observational
1,647
1 country
2
Brief Summary
Investigation of the clinical condition and safety in patients with cervical dystonia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2013
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 2, 2013
CompletedFirst Submitted
Initial submission to the registry
June 24, 2014
CompletedFirst Posted
Study publicly available on registry
June 26, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedJanuary 9, 2020
March 1, 2018
6.2 years
June 24, 2014
January 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall assessments of the improvement in the seriousness of seizures
Improvement is based on the 5 following elements: 1) Eminent improvement 2) Improvement 3) Improvement a little invariability 5) Exacerbation 6) It is not possible to judge
Up to 3 years
Study Arms (1)
E2014
Eligibility Criteria
Patients with cervical dystonia
You may qualify if:
- Patients with cervical dystonia
You may not qualify if:
- The patients who participated in this surveillance in the past
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eisai Co., Ltd.lead
Study Sites (2)
Unknown Facility
Osaka, Japan
Unknown Facility
Tokyo, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Akira Endo
Drug Fostering and Evolution Coordination Department, Eisai Co., Ltd.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2014
First Posted
June 26, 2014
Study Start
April 2, 2013
Primary Completion
June 30, 2019
Study Completion
June 30, 2019
Last Updated
January 9, 2020
Record last verified: 2018-03